Recent Advances of Novel Pharmaceutical Designs for Anti-cancer Therapies
This Special Issue covers a well-balanced collection of state-of-the-art topics in the prospering and competitive field of anticancer drug design and development, which can address and inspire oncologists, biologists, and medicinal chemists among the readership of this journal.
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_112567 | ||
| 005 | 20230808 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230808s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-8310-5 | ||
| 020 | |a 9783036583112 | ||
| 020 | |a 9783036583105 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-8310-5 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a MJCL |2 bicssc | |
| 100 | 1 | |a Biersack, Bernhard |4 edt | |
| 700 | 1 | |a Biersack, Bernhard |4 oth | |
| 245 | 1 | 0 | |a Recent Advances of Novel Pharmaceutical Designs for Anti-cancer Therapies |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (268 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This Special Issue covers a well-balanced collection of state-of-the-art topics in the prospering and competitive field of anticancer drug design and development, which can address and inspire oncologists, biologists, and medicinal chemists among the readership of this journal. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Oncology |2 bicssc | |
| 653 | |a illudin M | ||
| 653 | |a retinoic acid | ||
| 653 | |a neuronal cells | ||
| 653 | |a brain tumors | ||
| 653 | |a anticancer agents | ||
| 653 | |a PROTAC | ||
| 653 | |a target protein | ||
| 653 | |a protein degradation | ||
| 653 | |a indication | ||
| 653 | |a cinnamic acid derivatives | ||
| 653 | |a antiproliferative activity | ||
| 653 | |a microtubule | ||
| 653 | |a tubulin stabilizer | ||
| 653 | |a pterostilbene | ||
| 653 | |a melanoma | ||
| 653 | |a anticancer activity | ||
| 653 | |a apoptosis | ||
| 653 | |a proliferation | ||
| 653 | |a hepatocellular carcinoma | ||
| 653 | |a eIF4A1 | ||
| 653 | |a translation inhibitors | ||
| 653 | |a targeted therapies | ||
| 653 | |a heat shock proteins | ||
| 653 | |a Hsp70 | ||
| 653 | |a Hsp40 | ||
| 653 | |a anticancer | ||
| 653 | |a eEF1A | ||
| 653 | |a mechanism | ||
| 653 | |a macrocycle | ||
| 653 | |a heterocycle | ||
| 653 | |a gold | ||
| 653 | |a carbene ligands | ||
| 653 | |a metal-based drugs | ||
| 653 | |a esophageal cancer | ||
| 653 | |a carbonic anhydrases | ||
| 653 | |a colorectal cancer | ||
| 653 | |a consensus molecular subtypes | ||
| 653 | |a CMS | ||
| 653 | |a SLC-0111 | ||
| 653 | |a targeted inhibition of carbonic anhydrases | ||
| 653 | |a chemotherapy | ||
| 653 | |a curcumin | ||
| 653 | |a difluorinated curcumin | ||
| 653 | |a CDF | ||
| 653 | |a pancreatic cancer | ||
| 653 | |a PDAC | ||
| 653 | |a 2-hydroxypropyl-β-cyclodextrin | ||
| 653 | |a cyclodextrin | ||
| 653 | |a adenosine deaminases acting on RNA (ADAR) | ||
| 653 | |a anti-ADAR2 | ||
| 653 | |a natural products | ||
| 653 | |a cancer | ||
| 653 | |a depression | ||
| 653 | |a anxiety disorders | ||
| 653 | |a autism spectrum disorder (ASD) | ||
| 653 | |a molecular docking | ||
| 653 | |a molecular dynamics simulation | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7693 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/112567 |7 0 |z DOAB: description of the publication |